Mr. Chien Huang reports

PROXY DEADLINE THURSDAY SEPTEMBER 26, 2024

Titan Medical Inc. has released a reminder for shareholders to vote ahead of Titan's annual and special shareholders meeting scheduled to be held on Monday, Sept. 30, 2024.

Less than half of the Titan common shares have been voted in advance of the meeting. Vote today.

The management information circular and related materials for the meeting are available on Titan's website and under Titan's SEDAR+ profile.

For a recording of the Sept. 19, 2024, shareholders Q&A (question and answer) session, visit Titan's website.

Shareholder questions and assistance.

Shareholders who have any questions about the meeting, or require assistance with voting, may contact Shorecrest Group by telephone at 1-888-637-5789 or 1-647-931-7454 (bankers and brokers/collect calls outside North America).

About Titan Medical Inc.

Titan Medical, a medical technology company incorporated under the Business Corporations Act (Ontario) and headquartered in Toronto, Ont., has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property.

We seek Safe Harbor.